Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Insulet
PODD
Market cap
$22B
Overview
Fund Trends
Analyst Outlook
Journalist POV
312.45
USD
--5.85
1.84%
At close
Updated
Oct 15, 4:00 PM EDT
Pre-market
After hours
312.45
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-1.84%
5 days
-1.82%
1 month
-8.18%
3 months
7.75%
6 months
21.85%
Year to date
21.65%
1 year
35.81%
5 years
24.66%
10 years
928.47%
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
28.9%
Negative
Positive
Neutral
Negative
Neutral
Business Wire
5 days ago
Insulet to Host Investor Day on November 20, 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company's Acton, Massachusetts headquarters on Thursday, November 20, 2025. The Investor Day will include presentations from the management team highlighting the Company's longer-term strategic priorities, including market opportunities, innovation roadmap, as well as its longer-ter.
Positive
Zacks Investment Research
8 days ago
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Positive
Zacks Investment Research
16 days ago
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Zacks Investment Research
19 days ago
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?
PODD stock rallies 37.4% in a year, fueled by Omnipod 5 adoption, global launches and expanding reach in diabetes care.
Positive
Market Watch
23 days ago
These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process
Gains haven't been limited to the companies at the top of the S&P 500.
Neutral
Business Wire
27 days ago
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Pantone®, the global authority on color and provider of professional color standards for the design industries, today announced the creation of Omnipod Mango, a bright and joyful tropical orange yellow. Omnipod Mango was uniquely selected to celebrate the radiance of the diabetes community and symbolizes Insule.
Positive
Reuters
29 days ago
Medical device maker Insulet names industry veteran Flavia Pease as CFO
Medical device maker Insulet said on Tuesday that it appointed industry veteran Flavia Pease as its new chief financial officer and expects to exceed its previously issued third-quarter total revenue growth outlook.
Neutral
Business Wire
29 days ago
Insulet Announces CFO Transition
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor to Insulet to ensure a smooth transition. “I want to personally thank Ana, who has provided steady and thoughtful leader.
Positive
Zacks Investment Research
1 month ago
Here's Why Insulet (PODD) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
1 month ago
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close